Ubix Therapeutics

Website

Developer of pharmaceutical therapeutics designed to provide anti-cancer drugs based on proteolysis targeting chimera. The company uses inhibitor technology that degrades target proteins in cells and ...

Healthcare
Seoul, South Korea
Founded 2018
40 employees
Website
Valuation
$0
Share Price
N/A
Total Raised
$48M
Last Round
N/A
Investors
+27 other investors
View all 27 investors
Valuation History
0 funding rounds on record
Cap Table
Ownership structure
Market Activity
Secondary transactions

Get the full picture

Create a free account to unlock Ubix Therapeutics's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required